283 related articles for article (PubMed ID: 20345121)
21. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
[TBL] [Abstract][Full Text] [Related]
22. The biosynthesis of anticoagulant heparan sulfate by the heparan sulfate 3-O-sulfotransferase isoform 5.
Duncan MB; Chen J; Krise JP; Liu J
Biochim Biophys Acta; 2004 Mar; 1671(1-3):34-43. PubMed ID: 15026143
[TBL] [Abstract][Full Text] [Related]
23. GAG-ID: Heparan Sulfate (HS) and Heparin Glycosaminoglycan High-Throughput Identification Software.
Chiu Y; Huang R; Orlando R; Sharp JS
Mol Cell Proteomics; 2015 Jun; 14(6):1720-30. PubMed ID: 25887393
[TBL] [Abstract][Full Text] [Related]
24. Interaction of thrombospondin-1 and heparan sulfate from endothelial cells. Structural requirements of heparan sulfate.
Feitsma K; Hausser H; Robenek H; Kresse H; Vischer P
J Biol Chem; 2000 Mar; 275(13):9396-402. PubMed ID: 10734084
[TBL] [Abstract][Full Text] [Related]
25. Preparation and characterization of partial de-O-sulfation of heparin oligosaccharide library.
Lin J; Zheng L; Liang Q; Jiang L; Wei Z
Carbohydr Res; 2021 Jan; 499():108226. PubMed ID: 33401230
[TBL] [Abstract][Full Text] [Related]
26. Improved de novo sequencing of heparin/heparan sulfate oligosaccharides by propionylation of sites of sulfation.
Liang Q; Chopra P; Boons GJ; Sharp JS
Carbohydr Res; 2018 Jul; 465():16-21. PubMed ID: 29920400
[TBL] [Abstract][Full Text] [Related]
27. Isolation and characterization of low sulfated heparan sulfate sequences with affinity for lipoprotein lipase.
Spillmann D; Lookene A; Olivecrona G
J Biol Chem; 2006 Aug; 281(33):23405-13. PubMed ID: 16782967
[TBL] [Abstract][Full Text] [Related]
28. Investigation of the pharmacokinetic properties of synthetic heparan sulfate oligosaccharides.
Arnold K; Wang Z; Lucas A; Zamboni W; Xu Y; Liu J
Glycobiology; 2023 Mar; 33(2):104-114. PubMed ID: 36239422
[TBL] [Abstract][Full Text] [Related]
29. Autoantibodies to vascular heparan sulfate proteoglycan in systemic lupus erythematosus react with endothelial cells and inhibit the formation of thrombin-antithrombin III complexes.
Shibata S; Sasaki T; Harpel P; Fillit H
Clin Immunol Immunopathol; 1994 Feb; 70(2):114-23. PubMed ID: 8299226
[TBL] [Abstract][Full Text] [Related]
30. Screening enoxaparin tetrasaccharide SEC fractions for 3-O-sulfo-N-sulfoglucosamine residues using [(1)H,(15)N] HSQC NMR.
Beecher CN; Manighalam MS; Nwachuku AF; Larive CK
Anal Bioanal Chem; 2016 Feb; 408(6):1545-55. PubMed ID: 26758598
[TBL] [Abstract][Full Text] [Related]
31. A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential.
Brito AS; Cavalcante RS; Palhares LC; Hughes AJ; Andrade GP; Yates EA; Nader HB; Lima MA; Chavante SF
Carbohydr Polym; 2014 Jan; 99():372-8. PubMed ID: 24274520
[TBL] [Abstract][Full Text] [Related]
32. Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate.
Ashikari-Hada S; Habuchi H; Sugaya N; Kobayashi T; Kimata K
Glycobiology; 2009 Jun; 19(6):644-54. PubMed ID: 19254961
[TBL] [Abstract][Full Text] [Related]
33. Using structurally defined oligosaccharides to understand the interactions between proteins and heparan sulfate.
Xu D; Arnold K; Liu J
Curr Opin Struct Biol; 2018 Jun; 50():155-161. PubMed ID: 29684759
[TBL] [Abstract][Full Text] [Related]
34. Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants.
Lyon M; Deakin JA; Mizuno K; Nakamura T; Gallagher JT
J Biol Chem; 1994 Apr; 269(15):11216-23. PubMed ID: 8157651
[TBL] [Abstract][Full Text] [Related]
35. Anticoagulant heparan sulfate precursor structures in F9 embryonal carcinoma cells.
Zhang L; Yoshida K; Liu J; Rosenberg RD
J Biol Chem; 1999 Feb; 274(9):5681-91. PubMed ID: 10026187
[TBL] [Abstract][Full Text] [Related]
36. Structural studies of octasaccharides derived from the low-sulfated repeating disaccharide region and octasaccharide serines derived from the protein linkage region of porcine intestinal heparin.
Yamada S; Sakamoto K; Tsuda H; Yoshida K; Sugiura M; Sugahara K
Biochemistry; 1999 Jan; 38(2):838-47. PubMed ID: 9888825
[TBL] [Abstract][Full Text] [Related]
37. Oligosaccharide substrate preferences of human extracellular sulfatase Sulf2 using liquid chromatography-mass spectrometry based glycomics approaches.
Huang Y; Mao Y; Buczek-Thomas JA; Nugent MA; Zaia J
PLoS One; 2014; 9(8):e105143. PubMed ID: 25127119
[TBL] [Abstract][Full Text] [Related]
38. Unique extracellular matrix heparan sulfate from the bivalve Nodipecten nodosus (Linnaeus, 1758) safely inhibits arterial thrombosis after photochemically induced endothelial lesion.
Gomes AM; Kozlowski EO; Pomin VH; de Barros CM; Zaganeli JL; Pavão MS
J Biol Chem; 2010 Mar; 285(10):7312-23. PubMed ID: 20053999
[TBL] [Abstract][Full Text] [Related]
39. Resolving Heparan Sulfate Oligosaccharide Positional Isomers Using Hydrophilic Interaction Liquid Chromatography-Cyclic Ion Mobility Mass Spectrometry.
Cavallero GJ; Zaia J
Anal Chem; 2022 Feb; 94(5):2366-2374. PubMed ID: 35090117
[TBL] [Abstract][Full Text] [Related]
40. Improved liquid chromatography-MS/MS of heparan sulfate oligosaccharides via chip-based pulsed makeup flow.
Huang Y; Shi X; Yu X; Leymarie N; Staples GO; Yin H; Killeen K; Zaia J
Anal Chem; 2011 Nov; 83(21):8222-9. PubMed ID: 21923145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
